Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon-γ production against Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 196, Issue 9, 2007, Pages 1369-1378

  Quiroga, Maria Florencia ^a,b   Jurado, Javier Oscar ^a,b   Martínez, Gustavo Javier ^a,b   Pasquinelli, Virginia ^a,b   Musella, Rosa María ^c   Abbate, Eduardo ^c   Issekutz, Andrew C ^f   Bracco, María Marta ^d   Malbrán, Alejandro ^e   Sieling, Peter Allan ^g   Chuluyan, Eduardo ^a,b   García, Verónica Edith ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c Hospital FJ Muñiz   (Argentina)

^d INST DE INVEST HEMATOLOGICAS   (Argentina)

^e HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^f DALHOUSIE UNIVERSITY   (Canada)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD31 ANTIGEN; GAMMA INTERFERON; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TUBERCULOSTATIC AGENT; SH2D1A PROTEIN, HUMAN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; GENE EXPRESSION REGULATION; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM;

ANTIGENS, CD31; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 38449102872     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522522     Document Type: Article

References (35)

1. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
2. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, Barnes PF. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 1994; 94:2435-42.
3. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:3231-4.
4. Newman DK, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 2001; 97:2351-7.
5. Saito T. Negative regulation of T cell activation. Curr Opin Immunol 1998; 10:313-21.
6. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7:445-50.
7. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. CTLA-4 and T cell activation. Curr Opin Immunol 1999; 11:294-300.
8. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376:260-3.
9. Castro AG, Hauser TM, Cocks BG, et al. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J Immunol 1999; 163:5860-70.
10. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003; 4:19-24.
11. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999; 397:263-6.
12. Wang S, Zhu G, Chapoval AI, et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000; 96:2808-13.
13. Yoshinaga SK, Zhang M, Pistillo J, et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int Immunol 2000; 12:1439-47.
14. Riley JL, Blair PJ, Musser JT, et al. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement. J Immunol 2001; 166:4943-8.
15. Pasquinelli V, Quiroga MF, Martinez GJ, et al. Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-γ production in human tuberculosis. J Immunol 2004; 172:1177-85.
16. Quiroga MF, Pasquinelli V, Martinez GJ, et al. Inducible costimulator: a modulator of IFN-γ production in human tuberculosis. J Immunol 2006; 176:5965-74.
17. Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the coreceptor SLAM. Nature 1998; 395:462-9.
18. Quiroga MF, Martinez GJ, Pasquinelli V, et al. Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection. J Immunol 2004; 173:4120-9.
19. Newman PJ, Newman DK. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003; 23:953-64.
20. Demeure CE, Byun DG, Yang LP, Vezzio N, Delespesse G. CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 1996; 88:110-5.
21. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163:682-8.
22. Tomasello E, Blery M, Vely F, Vivier E. Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells. Semin Immunol 2000; 12:139-47.
23. Hamilton JK, Paquin LA, Sullivan JL, et al. X-linked lymphoproliferative syndrome registry report. J Pediatr 1980; 96:669-73.
24. Mehra V, Bloom BR, Bajardi AC, et al. A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. J Exp Med 1992; 175:275-84.
25. de la Barrera S, Aleman M, Musella R, et al. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin Exp Immunol 2004; 138:128-38.
26. Scimone ML, Lutzky VP, Zittermann SI, et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology 2005; 114:375-85.
27. Garcia VE, Sieling PA, Gong J, et al. Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol 1997; 159:1328-35.
28. Howie D, Sayos J, Terhorst C, Morra M. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus. Curr Opin Immunol 2000; 12:474-8.
29. Morra M, Howie D, Grande MS, et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol 2001; 19:657-82.
30. + T cells with interleukin-4 and interleukin-7. Pediatr Int 2000; 42:126-33.
31. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999; 162:6981-5.
32. Shlapatska LM, Mikhalap SV, Berdova AG, et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol 2001; 166:5480-7.
33. Chan B, Lanyi A, Song HK, et al. SAP couples Fyn to SLAM immune receptors. Nat Cell Biol 2003; 5:155-60.
34. Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol 1992; 148:388-96.
35. Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 2005; 166:185-96.